Nani said the state had no strategy for the development of the pharmaceutical industry before 1990 either and pharmaceuticals have been considered part of the chemical and petrochemical industries.
“Romania was never specialized in pharmaceuticals. Sustained efforts of communities or shareholders in Terapia, Sicomed, determined the existence of a production of pharmaceuticals in Romania. There has been no strategy so far. Let’s hope there will be one because the pharmaceutical industry keeps people employed and has major contributions to the state,” said Nani.
The output capacity of Romania’s top five medicines producers has increased by 50% in recent years. He said Romania’s current output stands at EUR600-650 million but the real capacity of the top producers is at least 40% higher.
“Current platforms in Romania could raise output to EUR1 billion. But a Romanian product sells for RON1.75 on average while other products cost an average RON3.5,” said Nani.